Download presentation
Presentation is loading. Please wait.
1
Nat. Rev. Urol. doi:10.1038/nrurol.2016.26
Figure 5 Imaging of 65-year-old patient with prostate cancer and diffuse bone metastases Figure 5 | Imaging of 65-year-old patient with prostate cancer and diffuse bone metastases. a | Bone scintigraphy demonstrates multiple bone metastases predominantly in the pelvis and ribs. b | Corresponding maximum-intensity projection of 68Ga-PSMA–PET shows considerably more bone metastases than bone scintigraphy. PSMA, prostate-specific membrane antigen. Maurer, T. et al. (2016) Current use of PSMA–PET in prostate cancer management Nat. Rev. Urol. doi: /nrurol
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.